Research database

SVF Research Library

Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 21 matching records.

Search the database

Evidence

Sort

21 results — page 1 of 1

Level BRandomized Controlled TrialPubMed
Repairing Peri-Anal Fistulas with regenerative cell therapeutics: study protocol for a double-blinded randomized controlled phase I-II trial from Denmark (REP-PAF).
Randomized Controlled Trial with a reported sample of 75 on Chronic Wound, Autoimmune Research, published in Trials (2026) — summary generated from the PubMed abstract.
2026
Trials
n = 75
Level BClinical TrialEurope PMC
Effects of Combined Intrathecal Mesenchymal Stem Cells and Schwann Cells Transplantation on Neuropathic Pain in Complete Spinal Cord Injury: A Phase II Randomized Active-Controlled Trial
Clinical Trial on Spinal Cord Injury, published in Cell Transplant (2025) — summary generated from the PubMed abstract.
2025
Cell Transplant
8 citations
Level CProspective StudyPubMed
Effectiveness of Stromal Vascular Fraction (SVF) and Platelet-Rich Plasma (PRP) in Patients With Knee Osteoarthritis: Protocol for a Phase 3, Prospective, Randomized, Controlled, Multicenter Study (SPOST Study).
Prospective Study on Knee Osteoarthritis, Osteoarthritis, Cartilage Damage, published in JMIR Res Protoc (2025) — summary generated from the PubMed abstract.
2025
JMIR Res Protoc
2 citations
Level BClinical TrialPubMed
Efficacy and safety of autologous adipose-derived stem cells in subjects with moderate to severe atopic dermatitis: a multicenter, randomized, single-blind, placebo-controlled, phase 2 trial.
Clinical Trial with a reported sample of 114 on Scar, published in Stem Cell Res Ther (2025) — summary generated from the PubMed abstract.
2025
Stem Cell Res Ther
n = 114
Level ARandomized Controlled TrialPubMed
Mesenchymal Stem/Stromal Cell Therapy for Radiation-Induced Xerostomia in Previous Head and Neck Cancer Patients: A Phase II Randomized, Placebo-Controlled Trial.
Randomized Controlled Trial with a reported sample of 120, published in Clin Cancer Res (2024) — summary generated from the PubMed abstract.
2024
Clin Cancer Res
17 citations
n = 120
Level BClinical TrialPubMed
Safety and feasibility of autologous adipose-derived stromal vascular fraction in the treatment of keloids: a phase one randomized controlled pilot trial.
Clinical Trial with a reported sample of 8 on Scar, published in Am J Stem Cells (2023) — summary generated from the PubMed abstract.
2023
Am J Stem Cells
5 citations
n = 8
Level BClinical TrialPubMed
Cartilage regeneration and inflammation modulation in knee osteoarthritis following injection of allogeneic adipose-derived mesenchymal stromal cells: a phase II, triple-blinded, placebo controlled, randomized trial.
Clinical Trial with a reported sample of 40 on Knee Osteoarthritis, Osteoarthritis, Cartilage Damage, Immune Modulation, published in Stem Cell Res Ther (2023) — summary generated from the PubMed abstract.
2023
Stem Cell Res Ther
70 citations
n = 40
Level ARandomized Controlled TrialPubMed
Clinical Efficacy and Safety of the Intra-articular Injection of Autologous Adipose-Derived Mesenchymal Stem Cells for Knee Osteoarthritis: A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial.
Randomized Controlled Trial with a reported sample of 261 on Knee Osteoarthritis, Osteoarthritis, Cartilage Damage, published in Am J Sports Med (2023) — summary generated from the PubMed abstract.
2023
Am J Sports Med
91 citations
n = 261
Level BClinical TrialPubMed
Intravenous transplantation of bone marrow-derived mesenchymal stromal cells in patients with multiple sclerosis, a phase I/IIa, double blind, randomized controlled study.
Clinical Trial on Neuroinflammation, Immune Modulation, published in Mult Scler Relat Disord (2023) — summary generated from the PubMed abstract.
2023
Mult Scler Relat Disord
Level BRandomized Controlled TrialPubMed
Follow-up Study to Evaluate the Long-term Safety and Efficacy of Darvadstrocel (Mesenchymal Stem Cell Treatment) in Patients With Perianal Fistulizing Crohn's Disease: ADMIRE-CD Phase 3 Randomized Controlled Trial.
Randomized Controlled Trial with a reported sample of 25 on Autoimmune Research, published in Dis Colon Rectum (2022) — summary generated from the PubMed abstract.
2022
Dis Colon Rectum
103 citations
n = 25
Level BRandomized Controlled TrialPubMed
Final Results of Allogeneic Adipose Tissue-Derived Mesenchymal Stem Cells in Acute Ischemic Stroke (AMASCIS): A Phase II, Randomized, Double-Blind, Placebo-Controlled, Single-Center, Pilot Clinical Trial.
Randomized Controlled Trial with a reported sample of 13 on Stroke Research, published in Cell Transplant (2022) — summary generated from the PubMed abstract.
2022
Cell Transplant
66 citations
n = 13
Level BRandomized Controlled TrialPubMed
Intra-Articular Injection of Autologous Adipose Tissue-Derived Mesenchymal Stem Cells for the Treatment of Knee Osteoarthritis: A Phase IIb, Randomized, Placebo-Controlled Clinical Trial.
Randomized Controlled Trial with a reported sample of 12 on Knee Osteoarthritis, Osteoarthritis, Cartilage Damage, published in Stem Cells Transl Med (2019) — summary generated from the PubMed abstract.
2019
Stem Cells Transl Med
366 citations
n = 12
Level BRandomized Controlled TrialPubMed
Treatment of knee osteoarthritis with intra-articular injection of autologous adipose-derived mesenchymal progenitor cells: a prospective, randomized, double-blind, active-controlled, phase IIb clinical trial.
Randomized Controlled Trial on Knee Osteoarthritis, Osteoarthritis, Cartilage Damage, Immune Modulation, published in Stem Cell Res Ther (2019) — summary generated from the PubMed abstract.
2019
Stem Cell Res Ther
Level BRandomized Controlled TrialPubMed
Safety and Efficacy of Mesenchymal Stem Cells for Radiation-Induced Xerostomia: A Randomized, Placebo-Controlled Phase 1/2 Trial (MESRIX).
Randomized Controlled Trial with a reported sample of 30, published in Int J Radiat Oncol Biol Phys (2018) — summary generated from the PubMed abstract.
2018
Int J Radiat Oncol Biol Phys
n = 30
Level CProspective StudyPubMed
Adipose-derived mesenchymal stem cells (AdMSC) for the treatment of secondary-progressive multiple sclerosis: A triple blinded, placebo controlled, randomized phase I/II safety and feasibility study.
Prospective Study on Neuroinflammation, published in PLoS One (2018) — summary generated from the PubMed abstract.
2018
PLoS One
119 citations
Level BRandomized Controlled TrialPubMed
Umbilical Cord-Derived Mesenchymal Stromal Cells (MSCs) for Knee Osteoarthritis: Repeated MSC Dosing Is Superior to a Single MSC Dose and to Hyaluronic Acid in a Controlled Randomized Phase I/II Trial.
Randomized Controlled Trial with a reported sample of 8 on Knee Osteoarthritis, Osteoarthritis, published in Stem Cells Transl Med (2018) — summary generated from the PubMed abstract.
2018
Stem Cells Transl Med
n = 8
Level BRandomized Controlled TrialEurope PMC
Phase I/II randomized controlled trial of autologous bone marrow-derived mesenchymal stem cell therapy for chronic stroke
Randomized Controlled Trial on Stroke Research, published in World J Stem Cells (2017) — summary generated from the PubMed abstract.
2017
World J Stem Cells
30 citations
Level BClinical TrialPubMed
A Prospective, Nonrandomized, no Placebo-Controlled, Phase I/II Clinical Trial Assessing the Safety and Efficacy of Intramuscular Injection of Autologous Adipose Tissue-Derived Mesenchymal Stem Cells in Patients With Sev
Clinical Trial with a reported sample of 17 on Peripheral Artery Disease, published in Cell Med (2016) — summary generated from the PubMed abstract.
2016
Cell Med
16 citations
n = 17
Level BClinical TrialPubMed
Human Umbilical Cord Mesenchymal Stromal Cell Transplantation in Myocardial Ischemia (HUC-HEART Trial). A Study Protocol of a Phase 1/2, Controlled and Randomized Trial in Combination with Coronary Artery Bypass Grafting
Clinical Trial with a reported sample of 79 on Cardiovascular Disease, published in Stem Cell Rev Rep (2015) — summary generated from the PubMed abstract.
2015
Stem Cell Rev Rep
n = 79
Level BRandomized Controlled TrialPubMed
Reparative therapy for acute ischemic stroke with allogeneic mesenchymal stem cells from adipose tissue: a safety assessment: a phase II randomized, double-blind, placebo-controlled, single-center, pilot clinical trial.
Randomized Controlled Trial on Stroke Research, published in J Stroke Cerebrovasc Dis (2014) — summary generated from the PubMed abstract.
2014
J Stroke Cerebrovasc Dis
Level BClinical TrialPubMed
A prospective, non-randomized, no placebo-controlled, phase Ib clinical trial to study the safety of the adipose derived stromal cells-stromal vascular fraction in idiopathic pulmonary fibrosis.
Clinical Trial with a reported sample of 14, published in J Transl Med (2013) — summary generated from the PubMed abstract.
2013
J Transl Med
191 citations
n = 14

In-depth reviewed studies (full Thai translation)

Evidence system

SVF Research Library

Repairing Peri-Anal Fistulas with regenerative cell therapeutics: study protocol for a double-blinded randomized controlled phase I-II trial from Denmark (REP-PAF).

Effects of Combined Intrathecal Mesenchymal Stem Cells and Schwann Cells Transplantation on Neuropathic Pain in Complete Spinal Cord Injury: A Phase II Randomized Active-Controlled Trial

Effectiveness of Stromal Vascular Fraction (SVF) and Platelet-Rich Plasma (PRP) in Patients With Knee Osteoarthritis: Protocol for a Phase 3, Prospective, Randomized, Controlled, Multicenter Study (SPOST Study).

Efficacy and safety of autologous adipose-derived stem cells in subjects with moderate to severe atopic dermatitis: a multicenter, randomized, single-blind, placebo-controlled, phase 2 trial.

Mesenchymal Stem/Stromal Cell Therapy for Radiation-Induced Xerostomia in Previous Head and Neck Cancer Patients: A Phase II Randomized, Placebo-Controlled Trial.

Safety and feasibility of autologous adipose-derived stromal vascular fraction in the treatment of keloids: a phase one randomized controlled pilot trial.

Cartilage regeneration and inflammation modulation in knee osteoarthritis following injection of allogeneic adipose-derived mesenchymal stromal cells: a phase II, triple-blinded, placebo controlled, randomized trial.

Clinical Efficacy and Safety of the Intra-articular Injection of Autologous Adipose-Derived Mesenchymal Stem Cells for Knee Osteoarthritis: A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial.

Intravenous transplantation of bone marrow-derived mesenchymal stromal cells in patients with multiple sclerosis, a phase I/IIa, double blind, randomized controlled study.

Follow-up Study to Evaluate the Long-term Safety and Efficacy of Darvadstrocel (Mesenchymal Stem Cell Treatment) in Patients With Perianal Fistulizing Crohn's Disease: ADMIRE-CD Phase 3 Randomized Controlled Trial.

Final Results of Allogeneic Adipose Tissue-Derived Mesenchymal Stem Cells in Acute Ischemic Stroke (AMASCIS): A Phase II, Randomized, Double-Blind, Placebo-Controlled, Single-Center, Pilot Clinical Trial.

Intra-Articular Injection of Autologous Adipose Tissue-Derived Mesenchymal Stem Cells for the Treatment of Knee Osteoarthritis: A Phase IIb, Randomized, Placebo-Controlled Clinical Trial.

Treatment of knee osteoarthritis with intra-articular injection of autologous adipose-derived mesenchymal progenitor cells: a prospective, randomized, double-blind, active-controlled, phase IIb clinical trial.

Safety and Efficacy of Mesenchymal Stem Cells for Radiation-Induced Xerostomia: A Randomized, Placebo-Controlled Phase 1/2 Trial (MESRIX).

Adipose-derived mesenchymal stem cells (AdMSC) for the treatment of secondary-progressive multiple sclerosis: A triple blinded, placebo controlled, randomized phase I/II safety and feasibility study.

Umbilical Cord-Derived Mesenchymal Stromal Cells (MSCs) for Knee Osteoarthritis: Repeated MSC Dosing Is Superior to a Single MSC Dose and to Hyaluronic Acid in a Controlled Randomized Phase I/II Trial.

Phase I/II randomized controlled trial of autologous bone marrow-derived mesenchymal stem cell therapy for chronic stroke

A Prospective, Nonrandomized, no Placebo-Controlled, Phase I/II Clinical Trial Assessing the Safety and Efficacy of Intramuscular Injection of Autologous Adipose Tissue-Derived Mesenchymal Stem Cells in Patients With Sev

Human Umbilical Cord Mesenchymal Stromal Cell Transplantation in Myocardial Ischemia (HUC-HEART Trial). A Study Protocol of a Phase 1/2, Controlled and Randomized Trial in Combination with Coronary Artery Bypass Grafting

Reparative therapy for acute ischemic stroke with allogeneic mesenchymal stem cells from adipose tissue: a safety assessment: a phase II randomized, double-blind, placebo-controlled, single-center, pilot clinical trial.

A prospective, non-randomized, no placebo-controlled, phase Ib clinical trial to study the safety of the adipose derived stromal cells-stromal vascular fraction in idiopathic pulmonary fibrosis.

In-depth reviewed studies (full Thai translation)

Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial

Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials

Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis